| Symbol | Company | Weighting |
|---|---|---|
| NTRA | NATERA INC | 5.19% |
| PCVX | VAXCYTE INC | 4.12% |
| LLY | ELI LILLY CORP | 3.71% |
| NVO | NOVO NORDISK A/S | 3.51% |
| BSX | BOSTON SCIENTIFIC | 3.03% |
| LNTH | LANTHEUS HOLDINGS INC | 2.68% |
| HCA | HCA HOLDINGS INC | 2.60% |
| TWST | TWIST BIOSCIENCE CORP USD 0.00001 | 2.57% |
| SYK | STRYKER CORP | 2.46% |
| VRTX | VERTEX PHARMACEUTICALS INC | 2.44% |
| ITCI | INTRA-CELLULAR THERAPIES USD | 2.22% |
| ZTS | ZOETIS INC | 2.09% |
| CYTK | CYTOKINETICS INC | 2.06% |
| AVTR | AVANTOR, INC. | 1.99% |
| UTHR | UNITED THERAPEUTICS CORPS | 1.96% |
| AZN | ASTRAZENECA PLC-ADR | 1.94% |
| TMO | THERMO FISHER SCIENTIFIC INC | 1.93% |
| ALNY | ALNYLAM PHARMACEUTICALS INC. | 1.87% |
| UNH | UNITEDHEALTH GROUP INC | 1.86% |
| ADUS | ADDUS HOMECARE CORPORATION | 1.85% |
| IDXX | IDEXX LABS CORP | 1.80% |
| SRPT | SAREPTA THERAPEUTICS INC | 1.78% |
| OPCH | OPTION CARE HEALTH, INC. | 1.78% |
| XENE | XENON PHARMACEUTICALS | 1.77% |
| DHR | DANAHER CORP | 1.71% |
| IQV | IQVIA HOLDINGS INC | 1.71% |
| RMD | RESMED INC | 1.70% |
| AMGN | AMGEN CORP | 1.70% |
| CI | THE CIGNA GROUP | 1.67% |
| GMED | GLOBUS MEDICAL INC CLASS A | 1.55% |
| MOH | MOLINA HEALTHCARE INC | 1.55% |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1.55% |
| WAT | WATERS CORP | 1.53% |
| BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.50% |
| JNJ | JOHNSON & JOHNSON | 1.48% |
| ACHC | ACADIA HEALTHCARE CO INC | 1.43% |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 1.42% |
| RVTY | REVVITY INC | 1.39% |
| TECH | BIO-TECHNE CORPORATION | 1.38% |
| DNLI | DENALI THERAPEUTICS INC. | 1.37% |
| BIO | BIO-RAD LABORATORIES INC | 1.34% |
| MASI | MASIMO CORP | 1.26% |
| APLS | APELLIS PHARMACEUTICALS INC | 1.20% |
| CRL | CHARLES RIVER LABORATORIES INT INC | 1.19% |
| PODD | INSULET CORP | 1.17% |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 1.11% |
| HUM | HUMANA INC | 1.07% |
| BIIB | BIOGEN INC | 1.04% |
| XNCR | XENCOR INC. | 1.03% |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 0.97% |
| MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. (CLASS A) | 0.97% |
| DXCM | DEXCOM INC | 0.93% |
| ILMN | ILLUMINA INC | 0.90% |
| ARVN | ARVINAS INC USD | 0.77% |
| NTLA | INTELLIA THERAPEUTICS INC | 0.65% |
| ABCL | ABCELLERA BIOLOGICS INC NPV | 0.29% |
| VLTO | VERALTO CORP | 0.23% |
| GRAL | GRAIL INC | 0.02% |
| MRTXES | CONTRA MIRATI THERAPEU + NPV | 0.00% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, and GS GAMMA Advisors, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2024 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.